Clinical trial
A Investigator Initiated Phase II Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
NCT00843037 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Investigator Initiated Phase II Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- March 14, 2022
- Enrollment
- 25 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.